Donor CMV-specific cytotoxic T lymphocytes

· University of Texas MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donor CMV-specific cytotoxic T lymphocytes, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection [Phase 2]

See pricing